trial group:Conventional treatment + Naoxintong capsule
Sponsors
The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Conditions
Acute coronary syndrome
Phase 4
A randomized controlled trial of Naoxintong Capsule to reduce major cardiovascular adverse events (MACE) in patients with acute coronary syndrome (ACS)
RecruitingChiCTR2000034871
Start: 2020-07-21Updated: 2022-11-07
A randomized controlled trial of Naoxintong Capsule to reduce major cardiovascular adverse events (MACE) in patients with acute coronary syndrome (ACS)
RecruitingITMCTR2000003509
Start: 2020-07-21Updated: 2023-02-20